Stay updated on Eplontersen in ATTR CM: Clinical Trial
Sign up to get notified when there's something new on the Eplontersen in ATTR CM: Clinical Trial page.

Latest updates to the Eplontersen in ATTR CM: Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedPublication information was added: a PubMed-listed study citation appears under Publications with automatic PubMed sourcing. The revision history was updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. This is an administrative version update with no visible alterations to study details.SummaryDifference0.0%

- Check48 days agoChange DetectedRevision: v3.4.3 is now shown on the page, replacing the previous Revision: v3.4.2.SummaryDifference0.0%

- Check69 days agoChange DetectedAdded the topic tag 'Amyloidosis' and a new resource entry for the Genetic and Rare Diseases Information Center on the study page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check77 days agoChange DetectedNon-significant site-wide updates including Revision: v3.4.2 and the removal of a government funding notice; these changes do not affect trial details or study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check84 days agoChange DetectedAdded a government funding lapse notice at the top of the page explaining possible data delays and directing users to opm.gov. Updated the site release version to Revision: v3.4.1 (replacing v3.4.0).SummaryDifference0.2%

Stay in the know with updates to Eplontersen in ATTR CM: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Eplontersen in ATTR CM: Clinical Trial page.